Nitrous oxide

Description

Nitrous oxide is a compressed, non-flammable gas classified as an oxidizer. It is designated under the United States Pharmacopeia (USP) and is identified by the UN number 1070.

Uses and Indications

This drug is indicated for use in medical settings where nitrous oxide is administered. The administration of nitrous oxide may pose hazards or contraindications; therefore, it is intended for use only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of nitrous oxide. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the absence of specific teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Administration of nitrous oxide is indicated for use via the respiratory route through inhalation. It is essential that this agent is administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of nitrous oxide.

Healthcare professionals must ensure they are familiar with the indications, effects, dosages, methods, frequency, and duration of administration prior to use. Due to the potential hazards associated with nitrous oxide, careful consideration of the patient's condition and the clinical context is necessary to determine the appropriateness of its use.

Contraindications

Administration of nitrous oxide may be hazardous or contraindicated in certain situations. It is essential to avoid breathing the gas directly. Additionally, contact with liquid nitrous oxide should be prevented to avoid exposure to eyes, skin, or clothing. The cylinder temperature must not exceed 125°F (52°C) to ensure safety. Furthermore, federal law prohibits dispensing this product without a prescription, emphasizing the need for proper medical oversight. It is also critical to retain this product label for reference.

Warnings and Precautions

The use of this product necessitates adherence to specific warnings and precautions to ensure safety and efficacy.

Hazardous Properties This product is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion. It poses significant risks, including rapid suffocation and potential anesthetic effects. Users must be aware that exposure can lead to frostbite, and inhalation of the gas should be strictly avoided.

Storage and Handling It is imperative to store and utilize this product in environments with adequate ventilation. All oil and grease must be kept away from the storage area. Equipment used must be specifically cleaned for nitrous oxide and rated for the cylinder pressure to prevent accidents. The cylinder temperature must not exceed 125°F (52°C).

Operational Guidelines When opening the valve, it should be done slowly to mitigate risks. The valve must be closed after each use and when the cylinder is empty. Users are advised to follow the guidelines outlined in the Material Safety Data Sheet (MSDS) to ensure safe handling. It is crucial to employ a backflow preventative device in the piping to prevent suck-back into the cylinder, which may lead to rupture.

First Aid Measures In the event of inhalation, the individual should be removed to fresh air immediately. If the person is not breathing, artificial respiration should be administered. If breathing difficulties arise, oxygen should be provided, and a physician must be contacted without delay. In cases of frostbite, immediate medical treatment is essential.

Adhering to these warnings and precautions is vital for the safe use of this product in clinical settings.

Side Effects

Patients using this product should be aware of several serious warnings and precautions associated with its use. The product is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion and can lead to rapid suffocation. Additionally, it may cause anesthetic effects and frostbite if not handled properly.

It is crucial for patients to avoid breathing in the gas and to ensure that the product is stored and used in an adequately ventilated area. Patients should keep oil and grease away from the product and use it only with equipment that has been cleaned for nitrous oxide and is rated for cylinder pressure. Direct contact with liquid should be avoided to prevent exposure to eyes, skin, or clothing.

The cylinder temperature must not exceed 125°F (52°C), and patients are advised to open the valve slowly and close it after each use or when empty. It is important to follow the guidelines outlined in the Material Safety Data Sheet (MSDS) to ensure safe handling.

Patients should be aware that suck-back into the cylinder may cause rupture, and a backflow preventative device should always be used in the piping. In the event of inhalation, patients should be removed to fresh air immediately. If breathing has ceased, artificial respiration should be administered, and if breathing is difficult, oxygen should be provided. Medical assistance should be sought promptly, especially in cases of frostbite, where immediate medical treatment is necessary.

Drug Interactions

There are currently no specific drug interactions or drug and laboratory test interactions identified for the product. As such, no dosage adjustments or monitoring recommendations are necessary at this time. Healthcare professionals are advised to remain vigilant and consult relevant resources for any updates regarding potential interactions as new data may emerge.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of nitrous oxide in pediatric patients may pose hazards or be contraindicated. It should only be used under the supervision of a licensed practitioner experienced in its administration. Special precautions are necessary when administering nitrous oxide to children, as they may exhibit increased sensitivity to its effects.

Geriatric Use

Elderly patients may not have specific dosage adjustments, safety concerns, or special precautions outlined in the drug insert for Nitrous Oxide. As there is no available information regarding the use of this agent in geriatric populations, healthcare providers should exercise caution when administering Nitrous Oxide to elderly patients.

It is advisable to monitor these patients closely for any potential adverse effects, given the lack of targeted data. Individual clinical judgment should guide the use of Nitrous Oxide in this demographic, considering the overall health status and comorbidities of the patient.

Pregnancy

Administration of nitrous oxide is contraindicated in pregnancy due to potential risks to fetal outcomes. The use of nitrous oxide should be restricted to licensed practitioners who are experienced in its administration, as improper use may pose significant hazards.

Healthcare professionals should be aware that nitrous oxide is classified as a high-pressure oxidizing liquid and gas, which may lead to anesthetic effects. Given these warnings, it is crucial to avoid the use of nitrous oxide in pregnant patients to mitigate any potential adverse effects on both the mother and the developing fetus.

Lactation

There is no information available regarding the use of Nitrous Oxide in nursing mothers or its effects on lactation. Consequently, the safety and excretion of Nitrous Oxide in breast milk, as well as its potential effects on breastfed infants, remain undetermined. Healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers on the use of this agent.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Furthermore, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous monitoring and supportive measures should be maintained until the patient is stabilized and any potential complications are addressed.

Documentation of the incident, including the substance involved, estimated dose, time of exposure, and any interventions performed, is vital for ongoing patient care and future reference.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has revealed several important safety considerations associated with the use of nitrous oxide. Reports indicate that administration may be hazardous or contraindicated, necessitating that it be used only by or under the supervision of a licensed practitioner experienced in its use.

The drug is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion and poses risks such as rapid suffocation and anesthetic effects. Additionally, exposure may lead to frostbite, and it is advised to avoid breathing the gas. Proper storage and usage require adequate ventilation, and precautions must be taken to keep oil and grease away from the gas.

It is critical to use equipment that is specifically cleaned for nitrous oxide and rated for cylinder pressure. Users are cautioned against allowing liquid to contact the eyes, skin, or clothing, and to ensure that cylinder temperatures do not exceed 125°F (52°C). Valves should be opened slowly and closed after each use or when empty.

The Material Safety Data Sheet (MSDS) should be followed closely, and users must be aware of the risk of suck-back into the cylinder, which may cause rupture. A backflow preventative device is recommended in the piping system. In the event of inhalation, individuals should be removed to fresh air, and if breathing is difficult, oxygen should be administered. Immediate medical treatment is advised for frostbite cases.

Patient Counseling

Healthcare providers should advise patients that the administration of nitrous oxide may be hazardous or contraindicated and is to be used only by or under the supervision of a licensed practitioner experienced in its use. It is essential that the practitioner is familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the hazards, contraindications, side effects, and necessary precautions associated with nitrous oxide.

Patients should be instructed to avoid breathing the gas and to ensure that the area is adequately ventilated during use. They must be cautioned to keep oil and grease away from the equipment and to use only apparatus that has been cleaned for nitrous oxide and is rated for cylinder pressure. It is critical to avoid contact with liquid nitrous oxide in the eyes, on the skin, or on clothing.

Providers should inform patients that the cylinder temperature should not exceed 125°F (52°C) and that the valve should be opened slowly. Patients must be reminded to close the valve after each use and when the cylinder is empty, and to follow the guidelines outlined in the Material Safety Data Sheet (MSDS).

Additionally, it is important to note that suck-back into the cylinder may cause rupture; therefore, patients should always use a backflow preventative device in the piping.

In the event of an emergency, healthcare providers should instruct patients that if nitrous oxide is inhaled, they should be removed to fresh air. If the patient is not breathing, artificial respiration should be administered, and if breathing is difficult, oxygen should be provided. Patients should be advised to call a physician immediately. In cases of frostbite, obtaining medical treatment promptly is crucial.

Storage and Handling

All cylinders must be securely stored and handled during use to ensure safety. The temperature of the cylinders should not exceed 125°F (52°C). It is essential to store and utilize the cylinders in areas with adequate ventilation to prevent the accumulation of gas.

To maintain safety, it is critical to keep oil and grease away from the gas. Equipment used with the gas must be specifically cleaned for nitrous oxide and rated for the appropriate cylinder pressure. After each use and when the cylinder is empty, the valve should be closed to prevent any unintended release of gas.

In accordance with safety protocols, the Material Safety Data Sheet (MSDS) should be referenced and followed. Additionally, a back flow preventative device must always be used in the piping to ensure safe operation.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Holston Gases, Inc. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)